May 23, 2026 11:06 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Honoured to visit the Missionaries of Charity today, says Rubio after Kolkata visit, arrives in Delhi | Marco Rubio's India visit begins in Kolkata: Trade, defence and Quad talks take centre stage | Third fuel price hike in India in 10 days: Here’s what you’ll pay now | Big twist in RG Kar case! Calcutta HC orders fresh probe into evidence destruction allegations | Pulwama mastermind Hamza Burhan shot dead in PoK by unknown gunmen: Reports | NIA arrests Kolkata man for spying for Pakistan intelligence network | Cockroach Janta Party X handle withheld! Founder Abhijeet Dipke launches comeback account | Bengal govt makes Vande Mataram compulsory in all madrasas, extends school directive | RBI on alert! Interest rate hike may be coming as rupee crashes to fresh low | Big relief for Maharashtra employees! Fadnavis govt hikes DA to 60%
Pfizer
WIKIMEDIA COMMONS

Spain expects to receive 20Mln Pfizer vaccine doses in early 2021: Spanish Health Minister

| @indiablooms | Nov 10, 2020, at 11:52 pm

Moscow/UNI: The Spanish government expects to receive 20 million doses of Pfizer vaccine by early 2021, said Spanish Health Minister Salvador Illa said on Tuesday.

Illa said that his country is planning to sign a contract with Pfizer and some other companies regarding delivery of the COVID-19 vaccine during the coming two weeks.

While speaking to the TVE channel he said that about 10 million people would be vaccinated through these vaccines "We estimate that we will receive about 20 million doses of Pfizer vaccine. It is a double dose vaccine, so about 10 million people can be vaccinated. The vaccines will be free, they will be distributed through the national health system."

The minster stated that the decision on who will receive the vaccine first would be determined by the experts from the health ministry and autonomous communities.

Illa added that there would be no problems with the delivery of the vaccine that must be kept at an ultralow temperature, as the producers guarantee the right temperature.

On Monday, German company BioNTech and its US partner Pfizer announced a successful third phase of clinical trials of the COVID-19 vaccine. It demonstrates over 90 percent efficiency in preventing the coronavirus disease, the companies said.  

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.